-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
Research reveals a potential new biotherapy for Alzheimer’s diseaseWhen tested in mice, the therapy reduced amyloid plaques, a characteristic feature of Alzheimer’s. No drug available today can prevent or… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
CAD106 and CNP520, potential new drug treatments for AD, are being investigated as potential treatments. This study is recruiting AD patients from across the U.S.
400 Bad Requesthttps://clinicaltrials.gov/ct2/show/study/NCT02565511?term=alzheimer&recrs=a&rank=9&show_locs=Y#locnYour browser sent a request that this server… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The body is a system. Researchers are using this to our advantage as the development of amyloid plaques is linked to retina thinning which is a symptom we can inexpensively monitor.
Alzheimer's one day may be predicted during eye exam: Noninvasive test may screen for disease before symptoms appear –… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
We currently have 5 million people living with AD today and projected to have 14 million people living with AD by 2050. Research continues to ask the fundamental questions about the characteristics of AD.
Alzheimer's tied to brain's 'waste removal system'A new… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
Sleep is for the weak? Dr. Bendlin and her team are taking sleep more seriously as their longitudinal study indicates that sleep deprivation is linked to biomarkers of AD.
The brain may clean out Alzheimer’s plaques during sleep | Science N… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
Sanfilippo syndrome is a rare and fatal form of AD that affects children. The dire need for more research and treatment options is felt by all populations in our communities.
Two-year-old boy with condition dubbed 'childhood Alzheimer’s' thought to be youngest ever diagnosed in UK | The I… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
A study in Virginia is recruiting to evaluate if irradiation is an effective treatment for plaques.
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
As the study of genetics continue to advance, often we are left with more questions in deciphering nature’s patterns.
Why some people with brain markers of Alzheimer's have no dementia — ScienceDailyA new study has uncovered why some people that have brain… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
Benzodiazepines are associated with increased risk of Alzheimer's disease — ScienceDailyThe use of benzodiazepines and related drugs (Z drugs) is associated with a modestly increased risk of Alzheimer’s disease, according to a recent study. -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
University College London analyzed trends in AD and dementias to see if there are any trends among different ethnicities but information also indicated that diagnosis differs. This reminds us that diagnoses aren’t an exact standard protocol but the best efforts put by our healthcare teams. We have to work together to continue the push for…[Read more]
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
MiR-132, a micro RNA, may another neuroprotective molecule that clinicians and researchers can utilize for treatment giving clinical teams more avenues to attack AD.
Newly characterized molecule offers possibilities for novel Alzheimer's treatments –… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The Alzheimer’s Prevention Registry is attempting to collect enough information to improve the diagnosis process for the future patients.
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The potential dangers of the things that we often take granted like the air we breathe or in this case the water we drink, can be linked to brain damage that takes years to become clinically significant and therefore nearly impossible to pin down on. Animal research in Taiwan is indicating that ultrasound is a possible mitigator in protecting the…[Read more]
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The liver may be playing a larger role in the development of AD. The influx of possibilities can be both overwhelming and exciting but it always comes back to the systems of the body being just parts to a larger whole.
A Gut–and Liver–Check to Get a Bead on Alzheimer's – Scientific… -
raineealexis posted an update in the group Multiple Sclerosis Advocate Network
Understanding a condition is the first step in finding effective ways to treat it, exciting research led by Dr. Arman Eshagh.
New research shows brain tissue loss follows a predictable sequence | MS International… -
raineealexis posted an update in the group Multiple Sclerosis Advocate Network
A study in the Philippines is recruiting to look at the efficacy of a single dose injection of stem cells in treating MS. There is a follow-up after 1 month, 3 months, 6 months and 12 months post-transplantation to evaluate the efficacy and saftey.…[Read more]
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
A multi-state study is recruiting to investigate whether Posiphen, which inhibits the formation of toxic plaques opposed to removing after formation, is a viable treatment.
400 Bad RequestYour browser sent a request that this… -
raineealexis posted an update in the group Multiple Sclerosis Advocate Network
Researchers and clinicians are slowly coming to a united front to tap into the wealth of knowledge the gut biome has concerning many conditions. Researchers think that lifestyle changes often result in improving the quality of life of those living with MS because it is estimated that 70% of the immune system is housed in the GI…[Read more]
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
BAN2401, a new drug being developed by Biogen and Eisai shows exciting results in Phase 1 and Phase 2 trials with reduction of plaques and slowing the progression of AD by estimated 30%.…[Read more]
-
raineealexis posted an update in the group Multiple Sclerosis Advocate Network
A major difficulty of living with a chronic disease is the dedication that treatment requires. A research center in Alabama is recruiting to look at the efficacy of delivering rehabilitation and exercise programs remotely as a form of…[Read more]
- Load More